levodopa has been researched along with pardoprunox in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bronzova, J; Hauser, RA; Lang, AE; Rascol, O; Sampaio, C; Theeuwes, A; van de Witte, SV | 2 |
| Jackson, MJ; Jenner, P; McCreary, AC; Rose, S; Tayarani-Binazir, K | 1 |
2 trial(s) available for levodopa and pardoprunox
| Article | Year |
|---|---|
Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's disease.
Topics: Aged; Benzoxazoles; Chemotherapy, Adjuvant; Dopamine Agonists; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Multivariate Analysis; Parkinson Disease; Piperazines; Treatment Outcome | 2009 |
Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial.
Topics: Adult; Aged; Antiparkinson Agents; Benzoxazoles; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Pain Measurement; Parkinson Disease; Piperazines; Severity of Illness Index; Time Factors; Treatment Outcome | 2012 |
1 other study(ies) available for levodopa and pardoprunox
| Article | Year |
|---|---|
The partial dopamine agonist pardoprunox (SLV308) administered in combination with l-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Area Under Curve; Benzoxazoles; Callithrix; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Motor Activity; Movement Disorders; Piperazines; Statistics, Nonparametric; Time Factors | 2010 |